Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches.
Bell
D
D
D003131:Combined Modality Therapy; D003422:Critical Care / Q000379:methods / Q000639:trends; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy*; D003927:Diet, Diabetic; D018450:Disease Progression; D005081:Exercise Therapy; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D007004:Hypoglycemic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000145:classification / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D007333:Insulin Resistance; D000078790:Insulin Secretion; D008019:Life Style; D009765:Obesity / Q000150:complications; D012307:Risk Factors
D007004:Hypoglycemic Agents; D007328:Insulin